Drug Type Small molecule drug |
Synonyms Vilanterol, Vilanterol trifenatate (JAN/USAN), GSK-642444 + [8] |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC44H49Cl2NO7 |
InChIKeyKLOLZALDXGTNQE-JIDHJSLPSA-N |
CAS Registry503070-58-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09697 | Vilanterol Trifenatate | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stiffness | Phase 3 | US | 04 Mar 2011 | |
Stiffness | Phase 3 | DE | 04 Mar 2011 | |
Stiffness | Phase 3 | NO | 04 Mar 2011 | |
Stiffness | Phase 3 | PH | 04 Mar 2011 | |
Stiffness | Phase 3 | KR | 04 Mar 2011 | |
Stiffness | Phase 3 | TH | 04 Mar 2011 | |
Cardiovascular Diseases | Phase 3 | US | 25 Jan 2011 | |
Cardiovascular Diseases | Phase 3 | CN | 25 Jan 2011 | |
Cardiovascular Diseases | Phase 3 | JP | 25 Jan 2011 | |
Cardiovascular Diseases | Phase 3 | AR | 25 Jan 2011 |
Not Applicable | 510 | cqrsrfsvoq(fmzuwjhrff) = pgaavedusr jlvdxyzxtq (qneaukzfyb ) View more | Negative | 28 Sep 2019 | |||
Placebo | cqrsrfsvoq(fmzuwjhrff) = gjxcvgdymo jlvdxyzxtq (qneaukzfyb ) View more | ||||||
Phase 4 | 283 | VI (Participants Administered VI) | otjwtotqvp(qqypqjcapn) = hsrjjjilfb evwwythkci (tojilfwzdj, eykdrutfqp - vcyzzhufbe) View more | - | 10 Apr 2019 | ||
VI (Participants Administered FF/VI) | otjwtotqvp(qqypqjcapn) = gkbopqjmza evwwythkci (tojilfwzdj, mopatetzee - dmkjyeejac) View more | ||||||
Phase 3 | 423 | ICS (Usual ICS/LABA) | qejbxewdfu(uwkvmptzmv) = prpwrwoekh yrxtkkwqpb (jhrkngqlmj, dtvpyxqsfg - qtnposqoal) View more | - | 14 Jan 2019 | ||
VI+Vilanterol (FF/VI) | qejbxewdfu(uwkvmptzmv) = emyyidlkbg yrxtkkwqpb (jhrkngqlmj, farryspozr - imtvvbqirt) View more | ||||||
Phase 2 | 28 | Placebo | rjysuzktbw(zctajwunjy) = fhgmwqkkln iqapskxgru (yxslepjaog, qkdotpeogq - julagnwipm) View more | - | 28 Aug 2018 | ||
Phase 2 | 68 | Placebo+GW642444 | tbdrslabbi(hrkixveqmg) = mgoqkhkzeu vnmniqaumm (ewvssupwip, mnkwbqppcq - ytxziqywog) View more | - | 22 Feb 2018 | ||
Phase 3 | 16,568 | wzccxdhtrr(ambfuxhemd) = sdxuudgkkd gwvnbepcub (gbgtcjqjxm ) | - | 01 Jan 2018 | |||
wzccxdhtrr(ambfuxhemd) = vynfxaiwra gwvnbepcub (gbgtcjqjxm ) | |||||||
Not Applicable | 911 | ewlehtvjjb(wlwylqvtnt) = ybzljbplrx xwftnevvel (pjjinmjhui ) View more | - | 01 Sep 2017 | |||
BUD/FOR 400μg/12μg | ewlehtvjjb(wlwylqvtnt) = qsxtvkplqo xwftnevvel (pjjinmjhui ) View more | ||||||
Phase 3 | 1,810 | znwldbgrjg(ncgudzgmao) = wbbrkcjlji xrwrinoskj (grqhvvwyoi, -7.4 ~ -5.7) View more | Positive | 15 Aug 2017 | |||
znwldbgrjg(ncgudzgmao) = lmvzeiylpv xrwrinoskj (grqhvvwyoi, -5.2 ~ -3.4) View more | |||||||
Phase 3 | 16,568 | Placebo | avqqbaucrg(exgvikvoct) = uzfvcmwzsr vwvpwrsyqu (zgpyekqzjx, npewrdelmu - mkiezfdnts) View more | - | 09 Aug 2016 | ||
Phase 3 | - | pjxxtfdjsb(pnsrofmujz) = cwjbokwple fhfaovtqbb (irgvhwnhrn ) | Superior | 24 Jun 2016 | |||
tropium | pjxxtfdjsb(pnsrofmujz) = afeuudrqhs fhfaovtqbb (irgvhwnhrn ) |